Angeles Investment Advisors LLC Sells 1,351 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Angeles Investment Advisors LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 51.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,269 shares of the healthcare conglomerate’s stock after selling 1,351 shares during the quarter. Angeles Investment Advisors LLC’s holdings in UnitedHealth Group were worth $640,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Axiom Financial Strategies LLC bought a new position in shares of UnitedHealth Group in the first quarter worth about $210,000. McGowan Group Asset Management Inc. boosted its stake in UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after buying an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after buying an additional 60,300 shares during the last quarter. MAS Advisors LLC boosted its stake in UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after buying an additional 45 shares during the last quarter. Finally, First Western Trust Bank bought a new position in UnitedHealth Group during the first quarter valued at approximately $875,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 66,081 shares of the firm’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the sale, the director now owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.4 %

Shares of NYSE:UNH traded down $1.87 on Friday, reaching $518.22. The company had a trading volume of 2,715,493 shares, compared to its average volume of 4,824,929. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70. The firm’s 50 day simple moving average is $525.36 and its 200-day simple moving average is $517.72. The firm has a market capitalization of $479.31 billion, a PE ratio of 21.74, a PEG ratio of 1.41 and a beta of 0.54. The company has a current ratio of 0.79, a quick ratio of 0.80 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business’s revenue was up 14.1% compared to the same quarter last year. During the same period last year, the business posted $5.34 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on UNH. StockNews.com lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 19th. Morgan Stanley lowered their price objective on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a research note on Monday, October 23rd. Finally, HSBC reaffirmed a “reduce” rating and issued a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. One analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $575.79.

Get Our Latest Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.